Aprio Wealth Management LLC boosted its holdings in shares of UnitedHealth Group Incorporated (NYSE:UNH – Free Report) by 15.9% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 1,337 shares of the healthcare conglomerate’s stock after buying an additional 183 shares during the period. Aprio Wealth Management LLC’s holdings in UnitedHealth Group were worth $676,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
Other hedge funds also recently added to or reduced their stakes in the company. Kathleen S. Wright Associates Inc. acquired a new position in UnitedHealth Group during the 3rd quarter valued at about $27,000. Global Wealth Strategies & Associates increased its holdings in shares of UnitedHealth Group by 152.4% in the third quarter. Global Wealth Strategies & Associates now owns 53 shares of the healthcare conglomerate’s stock valued at $31,000 after purchasing an additional 32 shares during the period. West Financial Advisors LLC acquired a new position in shares of UnitedHealth Group in the third quarter valued at about $32,000. Quarry LP increased its holdings in shares of UnitedHealth Group by 132.1% in the second quarter. Quarry LP now owns 65 shares of the healthcare conglomerate’s stock valued at $33,000 after purchasing an additional 37 shares during the period. Finally, RPg Family Wealth Advisory LLC acquired a new position in shares of UnitedHealth Group in the third quarter valued at about $37,000. 87.86% of the stock is owned by institutional investors and hedge funds.
Analyst Ratings Changes
A number of analysts have recently commented on the company. Truist Financial lowered their target price on UnitedHealth Group from $625.00 to $610.00 and set a “buy” rating on the stock in a research note on Monday, January 6th. Oppenheimer upped their target price on UnitedHealth Group from $610.00 to $640.00 and gave the stock an “outperform” rating in a research note on Friday, December 6th. Deutsche Bank Aktiengesellschaft increased their price target on UnitedHealth Group from $595.00 to $625.00 and gave the stock a “buy” rating in a research report on Tuesday, December 3rd. Piper Sandler lowered their price target on UnitedHealth Group from $605.00 to $600.00 and set an “overweight” rating on the stock in a research report on Thursday, January 2nd. Finally, UBS Group lowered their price target on UnitedHealth Group from $680.00 to $650.00 and set a “buy” rating on the stock in a research report on Wednesday, October 16th. Two equities research analysts have rated the stock with a hold rating, nineteen have given a buy rating and two have issued a strong buy rating to the company’s stock. Based on data from MarketBeat, the company currently has a consensus rating of “Buy” and an average price target of $626.79.
UnitedHealth Group Price Performance
UNH stock opened at $520.11 on Monday. The business has a fifty day moving average of $555.25 and a two-hundred day moving average of $562.50. The company has a quick ratio of 0.91, a current ratio of 0.91 and a debt-to-equity ratio of 0.74. The stock has a market cap of $478.65 billion, a price-to-earnings ratio of 33.88, a price-to-earnings-growth ratio of 1.53 and a beta of 0.62. UnitedHealth Group Incorporated has a 52-week low of $436.38 and a 52-week high of $630.73.
UnitedHealth Group (NYSE:UNH – Get Free Report) last released its quarterly earnings results on Tuesday, October 15th. The healthcare conglomerate reported $7.15 EPS for the quarter, topping the consensus estimate of $7.00 by $0.15. UnitedHealth Group had a return on equity of 26.37% and a net margin of 3.63%. The business had revenue of $100.82 billion during the quarter, compared to analyst estimates of $99.14 billion. During the same period last year, the business posted $6.56 earnings per share. The company’s quarterly revenue was up 9.2% on a year-over-year basis. As a group, research analysts anticipate that UnitedHealth Group Incorporated will post 27.61 earnings per share for the current year.
UnitedHealth Group Announces Dividend
The business also recently announced a quarterly dividend, which was paid on Tuesday, December 17th. Investors of record on Monday, December 9th were issued a $2.10 dividend. The ex-dividend date of this dividend was Monday, December 9th. This represents a $8.40 dividend on an annualized basis and a yield of 1.62%. UnitedHealth Group’s dividend payout ratio (DPR) is presently 54.72%.
About UnitedHealth Group
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.
See Also
- Five stocks we like better than UnitedHealth Group
- Are Penny Stocks a Good Fit for Your Portfolio?
- 3 Retail Stocks That Will Ring the Register in 2025
- Breakout Stocks: What They Are and How to Identify Them
- 3 Defensive Picks to Add Stability to Your Portfolio
- How to Invest in Tech Stocks and Top Tech Stocks to Consider
- AppLovin’s AI Potential: Can the Momentum Continue?
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.